mTOR signaling to translation

Current Topics in Microbiology and Immunology

Volumn 279, Issue , 2003, Pages 169-197

  Gingras, A C ^a,b   Raught, B ^a,b   Sonenberg, N ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOACYL TRANSFER RNA; CALYCULIN A; DNA; FK 506 BINDING PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE; RAPAMYCIN; TACROLIMUS; TARGET OF RAPAMYCIN KINASE; TOR1 PROTEIN; TOR2 PROTEIN; UNCLASSIFIED DRUG;

CELL GROWTH; CELL TYPE; ENZYME ACTIVITY; EUKARYOTE; GENETIC TRANSCRIPTION; GROWTH REGULATION; MAMMAL CELL; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; RIBOSOME; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; YEAST;

ANIMALS; HUMANS; MICE; PEPTIDE ELONGATION FACTORS; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; RIBOSOMES; SIGNAL TRANSDUCTION; SIROLIMUS;

EUKARYOTA; MAMMALIA; TOR;

EID: 0042823530     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (113)

1. Abraham RT, Wiederrecht GJ (1996) Immunopharmacology of rapamycin. Annu Rev Immunol 14:483-510
2. Altmann M, Wittmer B, Méthot N, Sonenberg N, Trachsel H (1995) The Saccharomyces cerevisiae translation initiation factor Tif3 and its mammalian homologue, eIF-4B, have RNA annealing activity. EMBO J 14:3820-3827
3. Andrade MA, Bork P (1995) HEAT repeats in the Huntington's disease protein. Nat Genet 11:115-116
4. Barbet NC, Schneider U, Helliwell SB, Stansfield I, Tuite MF, Hall MN (1996) TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell 7:25-42
5. Beck T, Hall MN (1999) The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature 402:689-692
6. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, et al. (1995) Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64:280-285
7. Beretta L, Gingras A-C, Svitkin YV, Hall MN, Sonenberg N (1996) Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 15:658-664
8. Berset C, Trachsel H, Altmann M (1998) The TOR (target of rapamycin) signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci USA 95:4264-4269
9. Bonneau AM, Sonenberg N (1987) Involvement of the 24-kDa cap-binding protein in regulation of protein synthesis in mitosis. J Biol Chem 262:11134-11139
10. Bosotti R, Isacchi A, Sonnhammer EL (2000) FAT: a novel domain in PIK-related kinases. Trends Biochem Sci 25:225-227
11. Brooks RF (1977) Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 12:311-317
12. Brown EJ, Schreiber SL (1996) A signaling pathway to translational control. Cell 86:517-520
13. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Darnell RB, Warren ST (2001) Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107:477-487
14. Brunn GJ, Fadden P, Haystead TAJ, Lawrence JC, Jr (1997a) The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus. J Biol Chem 272:32547-32550
15. Brunn GJ, Hudson CC, Sekulic A, Williams JM, Hosoi H, Houghton PJ, Lawrence JC, Jr, Abraham RT (1997b) Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277:99-101
16. Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci USA 95:1432-1437
17. Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-4245
18. Cardenas ME, Cutler NS, Lorenz MC, Di Como CJ, Heitman J (1999) The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev 13:3271-3279
19. Carter MS, Kuhn KM, Sarnow P (2000) Cellular Internal Ribosome Entry Site elements and the use of cDNA microarrays in their investigation. In: Sonenberg N, Hershey JWB, Mathews MB (eds). Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 615-635
20. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR (1992) AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 89:9267-9271
21. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR (1996) Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93:3636-3641
22. Cosentino GP, Schmelzle T, Haghighat A, Helliwell SB, Hall MN, Sonenberg N (2000) Eap1p, a novel eukaryotic translation initiation factor 4E-associated protein in Saccharomyces cerevisiae. Mol Cell Biol 20:4604-4613
23. Danaie P, Altmann M, Hall MN, Trachsel H, Helliwell SB (1999) CLN3 expression is sufficient to restore G1-to-S-phase progression in Saccharomyces cerevisiae mutants defective in translation initiation factor eIF4E. Biochem J 340:135-141
24. Dever TE (2002) Gene-specific regulation by general translation factors. Cell 108:545-556
25. Di Como CJ, Arndt KT (1996) Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev 10:1904-1916
26. Fadden P, Haystead TA, Lawrence JC, Jr (1997) Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. J Biol Chem 272:10240-10247
27. Fumagalli S, Thomas G (2000) S6 phosphorylation and signal transduction. In: Sonenberg N, Hershey JWB, Mathews MB (eds). Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 695-718
28. Gallego C, Gari E, Colomina N, Herrero E, Aldea M (1997) The Cln3 cyclin is down-regulated by translational repression and degradation during the G1 arrest caused by nitrogen deprivation in budding yeast. EMBO J 16:7196-7206
29. Gingras A-C, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N (1999) Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13:1422-1437
30. Gingras A-C, Kennedy SG, O'Leary MA, Sonenberg N, Hay N (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 12:502-513
31. Gingras A-C, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R, Sonenberg N (2001) Hierarchical phosphorylation of the translational inhibitor 4E-BP1. Genes Dev 15:2852-2864
32. Gingras A-C, Raught B, Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913-963
33. Gingras A-C, Raught B, Sonenberg N (2001) Control of translation by the target of rapamycin proteins. In: Rhoads RE (eds) Prog. Mol. Subcell. Biol. Springer-Verlag, Berlin, pp 143
34. Gingras AC, Raught B, Sonenberg N (2001) Regulation of translation initiation by FRAP/mTOR. Genes Dev 15:807-826
35. Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Kong X, Lin TA, Lawrence JC, Jr (1995) cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc Natl Acad Sci USA 92:7222-7226
36. Grolleau A, Bowman J, Pradet-Balade B, Puravs E, Hanash S, Garcia-Sanz JA, Beretta L (2002) Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J Biol Chem 277:22175-22184
37. Groves MR, Barford D (1999) Topological characteristics of helical repeat proteins. Curr Opin Struct Biol 9:383-389
38. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128-135
39. Hardwick JS, Kuruvilla FG, Tong JK, Shamji AF, Schreiber SL (1999) Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc Natl Acad Sci USA 96:14866-14870
40. Heesom KJ, Avison MB, Diggle TA, Denton RM (1998) Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor-4E binding protein 1 on the rapamycin-insensitive site (serine-111). Biochem J 336:39-48
41. Hellen CU, Sarnow P (2001) Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15:1593-1612
42. Hershey JWB, Merrick WC (2000) Pathway and mechanism of initiation of protein synthesis. In: Sonenberg N, Hershey JWB, Mathews MB (eds) Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 33-88
43. Hershey JWB, Miyamoto S (2000) Translational control and cancer. In: Sonenberg N, Hershey JWB, Mathews MB (eds). Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 637-654
44. Holcik M, Sonenberg N, Korneluk RG (2000) Internal ribosome initiation of translation and the control of cell death. Trends Genet 16:469-473
45. Hornstein E, Tang H, Meyuhas O (2001) Mitogenic and nutritional signals are transduced into translational efficiency of TOP mRNAs. In:(eds). The Ribosome (Cold Spring Harbor Symposia on Quantitative Biology LXVI). Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp. 477-484
46. Huang S, Houghton PJ (2002) Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr Opin Investig Drugs 3:295-304
47. Hunter T (1995) When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83:1-4
48. Jacinto E, Guo B, Arndt KT, Schmelzle T, Hall MN (2001) TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol Cell 8:1017-1026
49. Jackson RJ (2000) A comparative view of initiation site selection mechanisms. In: Sonenberg N, Hershey JWB, Mathews MB (eds) Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 127-183
50. Jang SK, Kräusslich H-G, Nicklin MJH, Duke GM, Palmenberg AC, Wimmer E (1988) A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62:2636-2643
51. Jiang Y, Broach JR (1999) Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast. EMBO J 18:2782-2792
52. Kahan BD (2000) Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 356:194-202
53. Kahan BD (2001) Sirolimus: a comprehensive review. 2:1903-1917
54. Karim MM, Hughes JMX, Warwicker J, Scheper GC, Proud CG, McCarthy JEG (2001) A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1. J Biol Chem 276:20750-20757
55. Keith CT, Schreiber SL (1995) PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270:50-51
56. Khaleghpour K, Pyronnet S, Gingras A-C, Sonenberg N (1999) Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol Cell Biol 19:4302-4310
57. Kimball SR, Jefferson LS (2000) Regulation of translation initiation in mammalian cells by amino acids. In: Sonenberg N, Hershey JWB, Mathews MB (eds). Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp. 561-580
58. Kohn AD, Barthel A, Kovacina KS, Boge A, Wallach B, Summers SA, Birnbaum MJ, Scott PH, Lawrence JC, Jr, Roth RA (1998) Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 273:11937-11943
59. Koromilas AE, Lazaris-Karatzas A, Sonenberg N (1992) mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J 11:4153-4158
60. Kozak M (1991) An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115:887-903
61. Kuruvilla FG, Shamji AF, Schreiber SL (2001) Carbon- and nitrogen-quality signaling to translation are mediated by distinct GATA-type transcription factors. Proc Natl Acad Sci USA 98:7283-7288
62. Lazaris-Karatzas A, Montine KS, Sonenberg N (1990) Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345:544-547
63. Leicht M, Simm A, Bertsch G, Hoppe J (1996) Okadaic acid induces cellular hypertrophy in AKR-2B fibroblasts: involvement of the p70S6 kinase in the onset of protein and rRNA synthesis. Cell Growth Differ 7:1199-1209
64. Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N, Lawrence JC, Jr (1994) PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266:653-656
65. Lodish HF (1974) Model for the regulation of mRNA translation applied to haemoglobin synthesis. Nature 251:385-388
66. Lodish HF (1976) Translational control of protein synthesis. Annu Rev Biochem 45:39-72
67. MacDonald A, The RAPAMUNE Global Study Group (2001) A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 71:271-280
68. Mahajan PB (1994) Modulation of transcription of rRNA genes by rapamycin. Int J Immunopharmacol 16:711-721
69. Manzella JM, Rychlik W, Rhoads RE, Hershey JW, Blackshear PJ (1991) Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phosphorylation of eucaryotic initiation factors eIF-4B and eIF-4E. J Biol Chem 266:2383-2389
70. Mathews MB, Sonenberg N, Hershey JWB (2000) Origins and principles of translational control. In: Sonenberg N, Hershey JWB, Mathews MB (eds). Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 1-31
71. Merrick WC, Nyborg J (2000) The protein biosynthesis elongation cycle. In: Sonenberg N, Hershey JWB, Mathews MB (eds). Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 89-125
72. Meyuhas O, Hornstein E (2000) Translational control of TOP mRNAs. In: Sonenberg N, Hershey JWB, Mathews MB (eds) Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 671-694
73. Mikulits W, Pradet-Balade B, Habermann B, Beug H, Garcia-Sanz JA, Mullner EW (2000) Isolation of translationally controlled mRNAs by differential screening. FASEB J 14:1641-1652
74. Mills GB, Lu Y, Kohn EC (2001) Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo. Proc Natl Acad Sci USA 98:10031-10033
75. Mothe-Satney I, Brunn GJ, McMahon LP, Capaldo CT, Abraham RT, Lawrence JC, Jr. (2000) Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies. J Biol Chem 275:33836-33843
76. Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ, Roth RA (1999) Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 274:21528-21532
77. Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, Frost P, Gibbons JJ, Wu H, Sawyers CL (2001) Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci USA 98:10314-10319
78. Nielsen FC, Ostergaard L, Nielsen J, Christiansen J (1995) Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature 377:358-362
79. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC (1999) A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19:1262-1270
80. Pause A, Belsham GJ, Gingras A-C, Donzé O, Lin TA, Lawrence JC, Jr, Sonenberg N (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371:762-767
81. Peiretti F, Raught B, Gingras A-C, Sonenberg N, Hershey JWB (2002) The eukaryotic translation initiation factor eIF4B is a substrate of the p70 ribosomal S6 kinase (S6 K) 1 (in preparation)
82. Pelletier J, Sonenberg N (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320-325
83. Peterson RT, Beal PA, Comb MJ, Schreiber SL (2000) FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem 275:7416-7423
84. Peterson RT, Desai BN, Hardwick JS, Schreiber SL (1999) Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin associated protein. Proc Natl Acad Sci USA 96:4438-4442
85. Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, Neshat M, Wang H, Yang L, Gibbons J, Frost P, Dreisbach V, Blenis J, Gaciong Z, Fisher P, Sawyers C, Hedrick-Ellenson L, Parsons R (2001) An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proc Natl Acad Sci USA 98:10320-10325
86. Polunovsky VA, Gingras A-C, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC, Bitterman PB (2000) Translational control of the antiapoptotic function of Ras. J Biol Chem 275:24776-24780
87. Polunovsky VA, Rosenwald IB, Tan A, White J, Chiang L, Sonenberg N, Bitterman PB (1996) Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol Cell Biol 16:6573-6581
88. Powers T, Walter P (1999) Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae. Mol Biol Cell 10:987-1000
89. Proud CG (2000) Control of the elongation phase of protein synthesis. In: Sonenberg N, Hershey JWB, Mathews MB (eds) Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 719-739
90. Pyronnet S, Gingras A-C, Bouisson M, Kowalski-Chauvel A, Seva C, Vaysse N, Sonenberg N, Pradayrol L (1998) Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA. Oncogene 16:2219-2227
91. Pyronnet S, Pradayrol L, Sonenberg N (2000) A cell cycle-dependent internal ribosome entry site. Mol Cell 5:607-616
92. Raught B, Gingras A-C, Gygi SP, Imataka H, Morino S, Gradi A, Aebersold R, Sonenberg N (2000) Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J 19:434-444
93. Raught B, Gingras A-C, James A, Medina D, Sonenberg N, Rosen JM (1996) Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. Cancer Res 56:4382-4386
94. Raught B, Gingras A-C, Sonenberg N (2000) Regulation of ribosomal recruitment in eukaryotes. In: Sonenberg N, Hershey JWB, Mathews MB (eds). Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 245-294
95. Raught B, Gingras A-C, Sonenberg N (2003) A novel mode of translational control: activation of 4E-BP1 phosphatases by rapamycin treatment, amino acid deprivation and environmental stresses (submitted)
96. Redpath NT, Foulstone EJ, Proud CG (1996) Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J 15:2291-2297
97. Rousseau D, Gingras A-C, Pause A, Sonenberg N (1996) The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 13:2415-2420
98. Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC, Sonenberg N (1990) Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol Cell Biol 10:1134-1144
99. Sabatini DM, Barrow RK, Blackshaw S, Burnett PE, Lai MM, Field ME, Bahr BA, Kirsch J, Betz H, Snyder SH (1999) Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. Science 284:1161-1164
100. Schmelzle T, Hall MN (2000) TOR, a central controller of cell growth. Cell 103:253-262
101. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21:99-102
102. Sonenberg N (1993) Remarks on the mechanism of ribosome binding to eukaryotic mRNAs. Gene Expr 3:317-323
103. Svitkin YV, Pause A, Haghighat A, Pyronnet S, Witherell G, Belsham GJ, Sonenberg N (2001) The requirement for eukaryotic initiation factor 4A (eIF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure. RNA 7:382-394
104. Tang H, Hornstein E, Stolovich M, Levy G, Livingstone M, Templeton D, Avruch J, Meyuhas O (2001) Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol 21:8671-1928
105. Thomas G, Hall MN (1997) TOR signalling and control of cell growth. Curr Opin Cell Biol 9:782-787
106. Vezina C, Kudelski A, Sehgal SN (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 28:721-726
107. von Manteuffel SR, Dennis PB, Pullen N, Gingras A-C, Sonenberg N, Thomas G (1997) The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6 k. Mol Cell Biol 17:5426-5436
108. von Manteuffel SR, Gingras A-C, Ming XF, Sonenberg N, Thomas G (1996) 4E-BP1 phosphorylation is mediated by the FRAP-p70s6 k pathway and is independent of mitogen-activated protein kinase. Proc Natl Acad Sci USA 93:4076-4080
109. Welsh EM, Wang W, Peltz SW (2000) Translation termination: it's not the end of the story. In: Sonenberg N, Hershey JWB, Mathews MB (eds) Translational control of gene expression. Cold Spring Harbor Laboratory Press, Plainview, N.Y., pp 467-485
110. West MJ, Stoneley M, Willis AE (1998) Translational induction of the c-myc oncogene via activation of the FRAP/mTOR signalling pathway. Oncogene 17:769-780
111. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 95:15587-15591
112. Zaragoza D, Ghavidel A, Heitman J, Schultz MC (1998) Rapamycin induces the G(0) program of transcriptional repression in yeast by interfering with the TOR signaling pathway. Mol Cell Biol 18:4463-4470
113. Zong Q, Schummer M, Hood L, Morris DR (1999) Messenger RNA translation state: the second dimension of high-throughput expression screening. Proc Natl Acad Sci USA 96:10632-10636